NetraMark Holdings Revenue

NetraMark Holdings had revenue of 620.36K CAD in the twelve months ending March 31, 2025, up 179.41% year-over-year. In the fiscal year ending September 30, 2024, NetraMark Holdings had annual revenue of 456.13K with 410.97% growth.

Revenue (ttm)

620.36K CAD

Revenue Growth

+179.41%

P/S Ratio

191.36

Revenue / Employee

n/a

Employees

n/a

Market Cap

82.59M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	456.13K	366.86K	410.97%
Sep 30, 2023	89.27K	-23.76K	-21.02%
Sep 30, 2022	113.03K	-	-
Sep 30, 2021	-	-	-
Sep 30, 2020	-	-	-
Sep 30, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo, Inc.	1.73B
Elite Pharmaceuticals	70.00M
Veradigm	588.02M
Tian'an Technology Group	1.78M
Northwest Biotherapeutics	1.47M
Glass House Brands	215.62M
American Oncology Network	1.76B
Silence Therapeutics	27.70M

Revenue Rankings

NetraMark Holdings News

2 months ago - NETRAMARK TO HOST SHAREHOLDER CONFERENCE CALL TO DISCUSS BUSINESS MOMENTUM - PRNewsWire
2 months ago - NETRAMARK AND WORLDWIDE CLINICAL TRIALS ANNOUNCE AGREEMENT TO TRANSFORM CLINICAL TRIAL DESIGN WITH AI-POWERED PRECISION - PRNewsWire
9 months ago - Netramark to Present at the 2024 Cantech Letter Conference in Toronto, ON - Newsfile Corp
2 years ago - NETRAMARK, THE FIRST PUBLIC AI COMPANY TO LAUNCH CLINICAL TRIAL DE-RISKING TECHNOLOGY THAT INTEGRATES CHATGPT - PRNewsWire

More News